Health Care & Life Sciences » Biotechnology | OSE Immunotherapeutics

OSE Immunotherapeutics

OSE Immunotherapeutics S.A.
Stock Exchange Euronext Paris
EPS
EUR0.34
Market Cap
EUR51.04 M
Shares Outstanding
14.82 M
Public Float
7.77 M

Profile

Address
22, boulevard Benoni Goullin
Nantes Pays-de-la-Loire (Loire Valley) 44000
France
Employees -
Website http://www.ose-immuno.com
Updated 07/08/2019
Develops immunotherapy products for late-stage cancers .

Dominique Costantini
Chairman
Alexis Peyroles
Chief Executive Officer & Director